These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9749276)

  • 1. [Betablocker therapy in acute myocardial infarction].
    Danchin N; Angioi M; Preiss JP; Jacquemin L; Houriez P
    Arch Mal Coeur Vaiss; 1998 Apr; 91 Spec No 2():43-7. PubMed ID: 9749276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.
    Azadpour M; Lamas GA
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):891-902. PubMed ID: 15500434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Audit of acute myocardial infarctions at Saint James's Hospital, Dublin, from 1996 to 1999.
    Pate GE; Curtin R; Talbot A; Murphy RT; Ward D; Barry M; Crean P; Foley JB; Walsh MJ
    Ir Med J; 2002 Oct; 95(9):274-6. PubMed ID: 12469999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry.
    Danchin N; Blanchard D; Steg PG; Sauval P; Hanania G; Goldstein P; Cambou JP; Guéret P; Vaur L; Boutalbi Y; Genès N; Lablanche JM;
    Circulation; 2004 Oct; 110(14):1909-15. PubMed ID: 15451803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).
    Koeth O; Zahn R; Gitt AK; Bauer T; Juenger C; Senges J; Zeymer U;
    Am J Cardiol; 2009 Oct; 104(8):1074-7. PubMed ID: 19801027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
    Arós F; Loma-Osorio A; Vila J; López-Bescós L; Cuñat J; Rodríguez E; San José JM; Heras M; Marrugat J;
    Rev Esp Cardiol; 2006 Apr; 59(4):313-20. PubMed ID: 16709383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolysis for acute myocardial infarction: drug review.
    Cundiff DK
    MedGenMed; 2002 Jan; 4(1):1. PubMed ID: 11965203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture].
    Sakai M; Imai T; Kuboki K; Maeda S; Ueda S; Kuwajima I; Ohkawa S; Matsushita S
    J Cardiol; 1999 Mar; 33(3):153-61. PubMed ID: 10225195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial.
    Latini R; Santoro E; Masson S; Tavazzi L; Maggioni AP; Franzosi MG; Barlera S; Calvillo L; Salio M; Staszewsky L; Labarta V; Tognoni G;
    Heart Dis; 2000; 2(3):185-90. PubMed ID: 11728260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug therapy of acute myocardial infarction without cardiogenic shock and thrombolytic therapy excluded].
    Roul G; Bareiss P; Mossard JM; Sacrez A
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):763-71. PubMed ID: 1356327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ACE inhibitors and angiotensin II receptor antagonists in acute coronary syndrome].
    Milicić D
    Acta Med Croatica; 2004; 58(2):129-34. PubMed ID: 15208798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive pharmacologic therapy for acute myocardial infarction.
    Pepine CJ
    Clin Cardiol; 1994 Jan; 17(1 Suppl 1):I10-4. PubMed ID: 7908862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [From the great clinical studies to the management of the single patient. Medical therapy in the pre- and post-fibrinolytic era].
    Mazzotta G; Piccininno M; Ricci D
    Ital Heart J; 2000 Jun; 1 Suppl 2():83-92. PubMed ID: 10905134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
    Second Chinese Cardiac Study (CCS-2) Collaborative Group
    J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
    Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P
    J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Which anti-ischemic treatment can be prescribed during and after the acute phase of myocardial infarction?].
    Delahaye F; Genoud JL; Colin C; Landrivon G; Ecochard R; Desseigne P; Pinzani A; André-Fouët X; Delaye J
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11):1567-74. PubMed ID: 1363772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction.
    Wienbergen H; Zeymer U; Gitt AK; Juenger C; Schiele R; Heer T; Towae F; Senges J;
    Am J Cardiol; 2007 May; 99(9):1208-11. PubMed ID: 17478143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality trends in men and women with acute myocardial infarction in coronary care units in Israel. A comparison between 1981-1983 and 1992-1994. For the SPRINT and the Israeli Thrombolytic Survey Groups.
    Gottlieb S; Goldbourt U; Boyko V; Harpaz D; Mandelzweig L; Khoury Z; Stern S; Behar S
    Eur Heart J; 2000 Feb; 21(4):284-95. PubMed ID: 10653676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical management after myocardial infarction: an evidence-based perspective.
    Sharpe N
    Br J Clin Pract Suppl; 1996 Jul; 84():25-30. PubMed ID: 8994999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.